A detailed history of American Capital Advisory, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, American Capital Advisory, LLC holds 2,398 shares of BMY stock, worth $131,194. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,398
Previous 8,058 70.24%
Holding current value
$131,194
Previous $413 Million 69.99%
% of portfolio
0.07%
Previous 0.3%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$39.66 - $51.75 $224,475 - $292,905
-5,660 Reduced 70.24%
2,398 $124 Million
Q4 2023

Apr 09, 2024

BUY
$48.48 - $57.85 $390,651 - $466,155
8,058 New
8,058 $413 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $116B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track American Capital Advisory, LLC Portfolio

Follow American Capital Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Advisory, LLC with notifications on news.